×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| Shyama Computronics and Servic | 0.70 | 0.19 | 0.61 | NA | 4.02 | 30.9 |
| Triochem Products Ltd., | 4.59 | 0.88 | NA | 3.60 | 0 | |
| CAPLIN POINT LABORATORIES LTD. | 5,243.20 | 1,400.70 | 4,929.60 | 18.19 | 15,429 | 30.0 |
| JUBILANT PHARMOVA LIMITED | 2144 | 53 | 1960 | 0.33 | 15404 | 46.2 |
| NATCO PHARMA LTD. | 6,511.00 | 1,324.00 | 4,748.00 | 7.43 | 14292 | 7.67 |
Caplin Point Laboratories Ltd., with Security Code 524742, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 116.3 | 136.9 | 130.6 | 144.6 | 173.6 | 179.2 | 132.8 | 139.3 | 185.6 | 207.9 |
| Expenses | 70.3 | 79.5 | 79.1 | 79.8 | 97.0 | 89.8 | 69.5 | 81.7 | 104.3 | 109.8 |
| Operating Profit | 46.1 | 57.4 | 51.5 | 64.9 | 76.6 | 89.5 | 63.3 | 57.7 | 81.4 | 98.2 |
| OPM % | 39.62% | 41.93% | 39.44% | 44.84% | 44.12% | 49.91% | 47.67% | 41.38% | 43.84% | 47.21% |
| Other Income | 35.0 | 22.5 | 29.4 | 12.2 | 27.3 | 24.5 | 17.9 | 36.2 | 21.5 | 43.0 |
| Interest | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Depreciation | 6.4 | 6.5 | 6.5 | 6.3 | 6.7 | 6.7 | 6.8 | 6.9 | 6.2 | 6.5 |
| Profit before tax | 74.7 | 73.3 | 74.4 | 70.8 | 97.2 | 107.2 | 74.4 | 86.9 | 96.7 | 134.7 |
| Tax % | 15.3% | 21.6% | 20.4% | 23.2% | 21.5% | 23.4% | 25.5% | 19.6% | 25% | 21.5% |
| Net Profit | 63.2 | 57.5 | 59.2 | 54.3 | 76.3 | 82.1 | 55.5 | 69.9 | 72.5 | 105.7 |
| EPS in Rs | 8.27 | 7.52 | 7.74 | 7.09 | 9.99 | 10.76 | 7.29 | 9.14 | 9.5 | 13.85 |
| Metrics | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 359.1 | 372.1 | 389.3 | 395.3 | 410.1 | 435.5 | 453.2 | 459.0 | 483.1 | 493.0 |
| Expenses | 253.5 | 262.7 | 265.4 | 268.7 | 272.7 | 293.2 | 308.0 | 307.2 | 318.4 | 330.7 |
| Operating Profit | 105.6 | 109.4 | 123.9 | 126.6 | 137.4 | 142.3 | 145.2 | 151.8 | 164.7 | 162.3 |
| OPM % | 29.4% | 29.4% | 31.8% | 32% | 33.5% | 32.7% | 32% | 33.1% | 34.1% | 32.9% |
| Other Income | 16.5 | 14.2 | 11.5 | 12.0 | 20.4 | 17.2 | 17.4 | 18.6 | 20.8 | 31.4 |
| Interest | 0.1 | 0.4 | 0.2 | 0.3 | 0.2 | 0.2 | 0.2 | 0.1 | 0.2 | 0.2 |
| Depreciation | 11.5 | 11.4 | 11.1 | 11.4 | 11.8 | 13.9 | 16.4 | 16.0 | 16.8 | 16.2 |
| Profit before tax | 110.5 | 111.7 | 124.0 | 127.0 | 145.9 | 145.4 | 146.0 | 154.4 | 168.5 | 177.3 |
| Tax % | 16.7% | 12.8% | 18.4% | 17.9% | 20.5% | 17.6% | 17% | 19.1% | 22.3% | 21% |
| Net Profit | 92.0 | 97.4 | 101.2 | 104.2 | 116.1 | 119.8 | 121.2 | 124.9 | 130.8 | 140.1 |
| EPS in Rs | 11 | 12 | 13 | 13 | 15 | 15 | 15 | 16 | 17 | 18 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 18% |
| 5 Years: | 3% |
| 3 Years: | 9% |
| TTM: | 14% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 35% |
| 5 Years: | 14% |
| 3 Years: | 23% |
| TTM: | 20% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 29% |
| 5 Years: | 45% |
| 3 Years: | 41% |
| 1 Year: | 35% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 30% |
| 5 Years: | 21% |
| 3 Years: | 17% |
| TTM: | 16% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 42% |
| 5 Years: | 21% |
| 3 Years: | 24% |
| TTM: | 18% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 29% |
| 5 Years: | 45% |
| 3 Years: | 41% |
| 1 Year: | 35% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|